InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Eisner Mark, VP Exécutif. Director active across 2 companies, notably Vir Biotechnology, Inc.. In total, 23 reports have been recorded. Split: 0 buy · 7 sells. Total volume traded: €426k. Activity tracked since 4 October 2021. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Eisner Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
1,616 股@ US$9.53260.0016% mcap50.0% 占其流量Common StockSEC:0001628280-26-012394:0
55,000 股0Common StockSEC:0001628280-26-011329:0
6,796 股@ US$5.468271.0% 占其流量Common StockSEC:0001628280-25-035269:0
40,000 股0Common StockSEC:0001628280-25-007699:0
75,000 股0Common StockSEC:0000950170-24-083951:0
1,860 股@ US$0.96310.2% 占其流量Common StockSEC:0001209191-23-048809:0
1,085 股@ US$1.060.1% 占其流量Common StockSEC:0001209191-23-048555:0
2,042 股@ US$17.0383.7% 占其流量Common StockSEC:0001209191-23-036054:0
1,090 股@ US$18.832.2% 占其流量Common StockSEC:0001209191-23-034288:0
9,182 股@ US$18.783818.1% 占其流量Common StockSEC:0001209191-23-023592:0
7,363 股@ US$21.155917.0% 占其流量Common StockSEC:0001209191-23-018063:0
1,187 股@ US$21.872.8% 占其流量Common StockSEC:0001209191-23-016362:0
32,500 股0Common StockSEC:0001209191-23-012425:0
1,084 股@ US$15.041.8% 占其流量Common StockSEC:0001209191-22-059472:0
6,777 股@ US$13.0110.3% 占其流量Common StockSEC:0001209191-22-052381:0
756 股@ US$13.091.1% 占其流量Common StockSEC:0001209191-22-048555:0
1,141 股@ US$9.612.8% 占其流量Common StockSEC:0001209191-22-034041:0
6,442 股@ US$12.0218.9% 占其流量Common StockSEC:0001209191-22-022095:0
756 股@ US$13.622.5% 占其流量Common StockSEC:0001209191-22-015366:0
60,000 股0Common StockSEC:0001209191-22-010452:0
7,043 股@ US$14.8224.8% 占其流量Common StockSEC:0001209191-22-001743:0
4,338 股@ US$12.6513.1% 占其流量Common StockSEC:0001209191-21-067780:0
74,520 股0Common StockSEC:0001209191-21-059869:0
23 条申报中的 23 条
About Eisner Mark
Eisner Mark is VP Exécutif, with listed roles at FIBROGEN INC, EVP, Chief Medical Officer, and at Vir Biotechnology, Inc., EVP and Chief Medical Officer. He has 23 filings in total, and across the sampled recent filings from 2021-10-06 to 2026-02-26, sales total 425980 EUR and the most common transaction nature is Retenue fiscale.
